Skip to main content
Clinical Trials/ACTRN12609000595213
ACTRN12609000595213
Completed
未知

Quality of life assessment and disease free survival and overall survival in patients with mulitple myeloma after Tandem Autologous Stem Cell Transplantation (ASCT)

Clifford Craig Medical Research Trust0 sites40 target enrollmentJuly 20, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Clifford Craig Medical Research Trust
Enrollment
40
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 20, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Clifford Craig Medical Research Trust

Eligibility Criteria

Inclusion Criteria

  • patients of either gender, 18 years and above who are able to give consent and have either: a confirmed diagnosis of multiple myeloma according to the World Health Organization (WHO) classification or patients who have been enrolled in our protocol with tandem stem cell transplantation

Exclusion Criteria

  • Patient with renal impairment defined by an estimated creatinine clearance below \< 15 ml/min based on the Cockcroft\-Gault formula. (Creatinine clearance \= (140\-age) x ideal body weight (IBW in Kg) (x 0\.85 if female) / (Serum creatinine. x 0\.815\).
  • Advanced liver disease (Child C with encephalopathy, ascites and a significantly elevated bilirubin, or pre\-treatment coagulopathy).
  • Patients with Eastern Cooperative Oncology Group (ECOG) status\>2

Outcomes

Primary Outcomes

Not specified

Similar Trials